Anaptysbio (ANAB) Current Leases (2020 - 2026)

Anaptysbio has reported Current Leases for 7 years, with the latest figure at $2.1 million in Q1 2026.

• For the quarter ending Q1 2026, Current Leases rose 8.05% year-over-year to $2.1 million; the trailing twelve-month figure through Mar 2026 stood at $2.1 million (up 8.05% YoY), and the FY2025 full-year result was $2.1 million, up 8.05% from the prior year.
• Current Leases for Q1 2026 stood at $2.1 million, up from $2.1 million in the prior quarter.
• The five-year high for Current Leases was $2.1 million in Q1 2026, with the low at $1.5 million in Q1 2022.
• Historically, Current Leases has averaged $1.8 million across 5 years, with a median of $1.8 million in 2024.
• Annual changes were most pronounced in 2022 — Current Leases jumped 182.88% — and 2025, when it grew 8.05%.
• Anaptysbio's Current Leases stood at $1.6 million in 2022, then rose by 8.55% to $1.8 million in 2023, then gained by 8.33% to $1.9 million in 2024, then climbed by 8.05% to $2.1 million in 2025, then advanced by 1.92% to $2.1 million in 2026.
• The last three Current Leases figures came in at $2.1 million (Q1 2026), $2.1 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.